OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Cell-free expression shows promise in preclinical applications but presents scale-up challenges.
Demand for recombinant microorganism-based cell culture supplements.
Biopharma responds to demand dynamics for upstream bioprocessing capacity.
June 02, 2021
Cell-free expression is promising in preclinical applications, but still presents challenges to scale up for commercial production.
May 19, 2021
VectorY, a Netherlands-based biotechnology company, has been selected as the European winner of MilliporeSigma’s 2021 Advance Biotech Grant Program.
May 02, 2021
Demand for recombinant microorganism-based cell culture supplements is rising on the back of lower contamination risk.
April 02, 2021
Biopharmaceutical companies and contract manufacturers respond to changing demand dynamics for upstream bioprocessing capacity.
The innovation of single-use technologies is applicable early on in the manufacturing process.
March 02, 2021
Overcoming time and cost constraints can help enable seed train intensification efforts to maximize product yield.
February 02, 2021
Connected, integrated bioprocessing enterprises with greater data analytics capabilities are coming.
January 02, 2021
Cell-culture optimization may see benefits from a synthetic biology-based approach that improves product titer, quality, and time.
December 02, 2020
Establishing an automated inline dilution system can potentially ease bottlenecking delays resulting from higher upstream yields.
November 02, 2020
PAT advances are enabling improved process understanding, process control, and error prevention.